Embolics
Total Payments
$105,619
Transactions
14
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $105,619 | 14 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $105,619 | 14 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SOLACE | Boston Scientific Corporation | $64,935 | 0 |
| Gastric Embolization as a Treatment for Morbid Obesity | Boston Scientific Corporation | $40,684 | 0 |
Top Doctors Receiving Payments for Embolics
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Portland, OR | $105,619 | 14 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $105,619
Product Information
- Type Device
- Total Payments $105,619
- Total Doctors 0
- Transactions 14
About Embolics
Embolics is a device associated with $105,619 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2017 to 2017. In 2017, $105,619 was paid across 14 transactions to 0 doctors.
The most common payment nature for Embolics is "Unspecified" ($105,619, 100.0% of total).
Embolics is associated with 2 research studies, including "SOLACE" ($64,935).